Exagen Overview
Exagen Target Price
Analysts' 12-month price predictions for XGN.
Get informed when a big investor buys or sells
+ FollowShare Price
$4.09
Average Target Price
$8.00
95.6% upside
95.6% upside3 analysts in the last 4 months
High: $8 | Low: $8
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-24 | Roth Capital | $8 | 95.6% upside |  |
| 2026-05-12 | BTIG | $8 | 95.6% upside | |
| 2026-04-20 | Canaccord Genuity | $8 | 95.6% upside | |
| 2026-03-11 | UBS | $10 | 144.5% upside | |
| 2026-03-10 | BTIGMark Massaro | $9 | 120% upside | |
| 2026-02-17 | BTIGMark Massaro | $10 | 144.5% upside | |
| 2025-10-27 | Canaccord Genuity | $15 | 266.7% upside | |
| 2025-10-14 | KeyBanc | $15 | 266.7% upside | |
| 2025-07-30 | Cantor Fitzgerald | $10 | 144.5% upside | |
| 2025-07-29 | KeyBanc | $12 | 193.4% upside | |
| 2024-11-12 | BTIGMark Massaro | $5 | 22.2% upside | |
| 2024-05-14 | Canaccord GenuityKyle Mikson | $5 | 22.2% upside | |
| 2022-11-17 | BTIG | $7 | 71.1% upside | |